HC Wainwright & Co. Reiterates Buy on Omega Therapeutics, Maintains $12 Price Target

Benzinga · 05/13 10:35
HC Wainwright & Co. analyst Robert Burns reiterates Omega Therapeutics (NASDAQ:OMGA) with a Buy and maintains $12 price target.